EverSource Wealth Advisors’s Bright Minds Biosciences DRUG Stock Holding History
Bought
Maintained
Sold
Other funds holding DRUG
EverSource Wealth Advisors's DRUG Position: Q3 2026 in Review
EverSource Wealth Advisors opened a new position in Bright Minds Biosciences (DRUG) in Q3 2026: 3 shares worth $150. The stake represents ﹤0.01% of the portfolio and ranks #4356 among its holdings.
58 funds tracked by Wall St. Rank hold DRUG as of Q3 2026.
- EverSource Wealth Advisors held 3 shares of Bright Minds Biosciences worth $150 as of Q3 2026.
- Bright Minds Biosciences was a new EverSource Wealth Advisors position in Q3 2026.
- Bright Minds Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4356 holding.
- 58 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2026.
Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.